Cargando…

Azilsartan/chlorthalidone combination therapy for blood pressure control

BACKGROUND: Edarbyclor(®) is a combined angiotensin receptor blocker (ARB) and thiazide-like diuretic (azilsartan and chlorthalidone), and was approved on December 20, 2011 by the US Food and Drug Administration (FDA) for hypertension management. OBJECTIVE: To review the pharmacology, pharmacokineti...

Descripción completa

Detalles Bibliográficos
Autor principal: Cheng, Judy WM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685454/
https://www.ncbi.nlm.nih.gov/pubmed/23807859
http://dx.doi.org/10.2147/IBPC.S34792